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emotional picture stimuli on cognitive processing effects of
subthreshold depression group in the behavioral and ERP, and
the differences from healthy people.
Methods: The design plan adopted with the Oddball
paradigm and divided into three blocks. In each block, the
emotional picture as the target stimulus (probability 20%),
were positive, neutral, negative, in a standard table for deviant
stimuli (probability 80%). The mixture design, 2 (Subthreshold
Depression group, control group)*3(positive, neutral, negative
pictures), was used the 64 conductive polar cap with 10-20
electrode lead positioning standard made by International
Society of EEG to record data, and make overlaying classiﬁca-
tion of right response EEG to get three types of ERP of positive,
neutral, negative pictures. Then it automatically measure
the amplitude and peak latency to analyze components of
responding, N2 and P3.
Results: At the RT, the main effect and the main effect
of stimulus type were both signiﬁcant. The amplitude and
latency of N2 and P3 both showed that main effect of group
was insigniﬁcant, while main effect of stimulus type was
signiﬁcant.
Conclusion: The result shows subthreshold depression
individuals give too much focus on negative emotion stimulus
and deeper cognitive processing to form negative cognitive
bias when they are faced with different valence emotional
picture stimuli. As a result, this hypothesis is invalid, which
means there is no difference between subthreshold depres-
sion population and healthy people in the aspect of emotional
stimuli on cognitive processing, which is not similar with the
cognitive processing of subthreshold depression population
in reports.
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Purpose: The dry ripe fruit of the Akebia quinata (A.
quinata) plant is used as an analgesic, an antiphlogistic, and a
diuretic in traditional medicine. A. quinata has also been used
in Korea as a crude drug for treating obesity. The aim of the
study was to determine the anti-obesity and hypolipidemic
effects of Akebia quinata extract (AQE) in mice consuming a
high-fat diet and in 3T3-L1 adipocytes.
Methods: We measured obesity-related physiological
parameters, gene expression, and protein phosphorylation
in mice consuming a high-fat diet supplemented with AQE
(400mg/kg/day) for 6.5 weeks.
Results: AQE reduced gain in body weight, adipose tissue
weight, and serum lipid levels in mice consuming a high-
fat diet. AQE supplementation reduced expression of genes
related to adipogenesis and increased expression of PPARa,
acetyl-CoA oxidase, and adiponectin in the epididymal adi-
pose tissue. Furthermore, AQE increased phosphorylation of
adenosine monophosphate-activated protein kinase (AMPK)
and acetyl-CoA carboxylase, both of which are related to
fatty acid oxidation, in vivo. HPLC analysis revealed that
AQE contained chlorogenic acid, isochlorogenic acid A, and
isochlorogenic acid C. AQE and all of these constituents
inhibited differentiation of 3T3-L1 cells and enhanced AMPK
phosphorylation.
Conclusion: These results suggest the AQE exerted anti-
obesity and hypolipidemic effects in mice consuming a high-
fat diet by regulating adipogenesis and fatty acid oxidation via
AMPK activation.
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Purpose: The present study aimed to evaluate the poten-
tial synergism of EA and a subeffective dosage of milnacipran
(selective norepinephrine reuptake inhibitor; SNRI) in the rat
model of neuropathic pain.
Methods: Mechanical and thermal hypersensitivity were
assessed by measuring paw withdrawal threshold and latency
in res ponse tomechanical and thermal stimuli, respectively, 1
day prior to the neuropathic surgery, as well as 5 days postop-
eratively. 10Hz EA was given at “ST36” and “GB34” acupoints
for 30min.
Results: Milnacipran (5, 20 ug, intrathecally) exerted dose-
dependent effect on thermal hyperalgesia, but exhibited
similar efﬁcacy on mechanical allodynia. EA itself detectably
attenuated thermal hyperalgesia at 4hours after the applica-
tion, and similar tendencywas found inmechanical allodynia,
but there was no statistically signiﬁcant difference. Co-
treatment with EA and milnacipran produced more potent
antiallodynia and antihyperalgesia compared to that obtained
from each component alone at 4, 6hours after the treatment,
which showed synergistic inhibitory effects. (4) The analgesia
of the combination of EA and milnacipran, was reduced by i.t.
pretreatment of yohimbine (a2-adrenoceptor antagonist, 30
ug), and the catecholamine neurotoxin 6-hydroxydopamine
hydrobromide (6-OHDA, 25 ug), which depleted spinal nor-
adrenaline (NA).
Conclusion: The ﬁndings indicate that combination treat-
ment of EA and a SNRI(milnacipran) synergistically inhibits
allodynia and hyperalgesia via the deactivation of spinal
noradrenergic systems coupled with spinal a2-adrenoceptors.
It is meaningful that the combination of EA and mil-
nacipran, which might be a promising treatment, is clinically
applicated in case s in which EA per se has proven
inefﬁcient.
